Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

Diabetologia. 2009 Sep;52(9):1971-3. doi: 10.1007/s00125-009-1452-2. Epub 2009 Jul 16.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Retinopathy / epidemiology
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin Glargine
  • Insulin, Isophane / adverse effects*
  • Insulin, Long-Acting
  • Neoplasms / epidemiology*
  • Risk Factors

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine
  • Insulin, Isophane